Introduction: Zhejiang New Donggang Pharmaceutical Co., Ltd. is a cardiovascular drug developer mainly engaged in the research and development of cardiovascular, anti-infective, anti-tumor and nervous system drugs. Its leading products include Norfloxacin, atorvastatin, rosuvastatin, sertraline hydrochloride and other raw materials and preparations.
Legal representative: Wei Zhanjiang
Establishment date: 2001-01-18
Registered capital: 160 million yuan
Industrial and commercial registration number ：3300001007547
Enterprise type: Other joint stock limited company (unlisted)
Company address: No. 29, Binhai Road, Jiaojiang District, Taizhou City, Zhejiang Province